AbbVie reports $1.3 billion Q4 expense from acquired research deals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. OKTA
3. MCD
4. ORCL
5. P
6. MGM
7. SPY
8. KGC
9. SFIX
10. GDDY

Go back to AbbVie reports $1.3 billion Q4 expense from acquired research deals
AbbVie (NYSE: ABBV) Delayed: 263.97 -1.11 (0.42%)
Previous Close $265.08    52 Week High $68.12 
Open $265.37    52 Week Low $50.71 
Day High $267.41    P/E 57.26 
Day Low $263.09    EPS $4.61 
Volume 1,191,114